Edwards Lifesciences Corporation Peer Comparison
| Metric | Value | Ranking | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $41.7 Billion | 5/10 | ABT $219.9B |
BSX $149.8B |
SYK $142.8B |
MDT $117.0B |
EW $41.7B |
DXCM $29.4B |
ZBH $22.3B |
PODD $18.7B |
ALGN $12.4B |
TNDM $1.4B |
| Gross Margin | 81% | 1/10 | EW 81% |
PODD 72% |
ALGN 70% |
BSX 68% |
MDT 66% |
SYK 65% |
DXCM 59% |
TNDM 56% |
ABT 55% |
ZBH 0% |
| Profit Margin | 100% | 1/10 | EW 100% |
ABT 84% |
PODD 17% |
MDT 16% |
DXCM 14% |
BSX 12% |
ALGN 10% |
SYK 8% |
ZBH 0% |
TNDM 0% |
| EBITDA margin | 30% | 1/10 | EW 30% |
MDT 29% |
ABT 27% |
BSX 22% |
DXCM 22% |
PODD 18% |
ALGN 14% |
SYK 9% |
TNDM 1% |
ZBH -100% |
| Quarterly Revenue | $1.4 Billion | 5/10 | ABT $11.0B |
MDT $8.3B |
SYK $6.4B |
BSX $4.6B |
EW $1.4B |
DXCM $1.1B |
ALGN $995.2M |
PODD $597.5M |
TNDM $282.6M |
ZBH $0 |
| Quarterly Earnings | $3.1 Billion | 2/10 | ABT $9.2B |
EW $3.1B |
MDT $1.3B |
BSX $566.0M |
SYK $546.0M |
DXCM $151.7M |
ALGN $103.8M |
PODD $100.7M |
TNDM $755,000 |
ZBH -$0 |
| Quarterly Free Cash Flow | $319.9 Billion | 4/10 | ABT $2.1B |
MDT $2.1B |
BSX $1.2B |
EW $319.9M |
DXCM $176.8M |
TNDM -$38.8M |
ZBH -$0 |
SYK -$0 |
PODD -$0 |
ALGN -$0 |
| Trailing 4 Quarters Revenue | $5.9 Billion | 5/10 | ABT $42.0B |
MDT $33.2B |
SYK $22.6B |
BSX $16.7B |
EW $5.9B |
ZBH $5.7B |
DXCM $4.0B |
ALGN $4.0B |
PODD $1.9B |
TNDM $1.1B |
| Trailing 4 Quarters Earnings | $4.2 Billion | 3/10 | ABT $11.0B |
MDT $8.3B |
SYK $6.4B |
BSX $4.6B |
EW $1.4B |
DXCM $1.1B |
ALGN $995.2M |
PODD $597.5M |
TNDM $282.6M |
ZBH -$0 |
| Quarterly Earnings Growth | 698% | 1/10 | EW 698% |
ABT 479% |
TNDM 103% |
BSX 12% |
ZBH 0% |
MDT -2% |
PODD -3% |
ALGN -16% |
DXCM -41% |
SYK -52% |
| Annual Earnings Growth | 218% | 1/10 | EW 218% |
ABT 127% |
PODD 62% |
ZBH 36% |
TNDM 25% |
MDT 5% |
DXCM -7% |
SYK -7% |
BSX -8% |
ALGN -14% |
| Quarterly Revenue Growth | -9% | 9/10 | TNDM 44% |
BSX 22% |
PODD 17% |
SYK 11% |
DXCM 8% |
ABT 7% |
ALGN 4% |
MDT 3% |
EW -9% |
ZBH -100% |
| Annual Revenue Growth | -3% | 10/10 | TNDM 41% |
BSX 17% |
SYK 10% |
PODD 5% |
MDT 4% |
ZBH 4% |
ALGN 4% |
ABT 3% |
DXCM 2% |
EW -3% |
| Cash On Hand | $3.7 Billion | 2/10 | ABT $7.6B |
EW $3.7B |
SYK $3.7B |
MDT $1.2B |
ALGN $1.0B |
PODD $953.4M |
DXCM $606.1M |
ZBH $525.5M |
BSX $414.0M |
TNDM $69.2M |
| Short Term Debt | $24.2 Million | 9/10 | SYK $12.2B |
MDT $2.6B |
BSX $1.8B |
ABT $1.5B |
DXCM $1.2B |
ZBH $863.0M |
PODD $83.8M |
TNDM $58.9M |
EW $24.2M |
ALGN -$0 |
| Long Term Debt | $682.5 Million | 6/10 | MDT $24.0B |
ABT $13.5B |
BSX $9.4B |
ZBH $5.3B |
DXCM $1.3B |
EW $682.5M |
TNDM $414.7M |
ALGN $88.2M |
SYK $0 |
PODD $0 |
| PE | 10.03 | 9/10 | BSX 80.98 |
DXCM 50.94 |
SYK 47.71 |
PODD 44.63 |
ZBH 33.50 |
ALGN 29.49 |
MDT 27.46 |
ABT 16.41 |
EW 10.03 |
TNDM -1.00 |
| PS | 7.10 | 4/10 | PODD 9.82 |
BSX 8.95 |
DXCM 7.28 |
EW 7.10 |
SYK 6.32 |
ABT 5.24 |
ZBH 3.93 |
MDT 3.52 |
ALGN 3.11 |
TNDM 1.29 |
| PB | 4.34 | 6/10 | PODD 15.41 |
DXCM 13.96 |
BSX 6.81 |
TNDM 5.21 |
ABT 4.59 |
EW 4.34 |
SYK 3.32 |
ALGN 3.23 |
MDT 2.36 |
ZBH 1.54 |
| PC | 11.35 | 10/10 | BSX 361.85 |
MDT 94.35 |
DXCM 48.43 |
ZBH 42.34 |
SYK 39.10 |
ABT 28.87 |
TNDM 19.80 |
PODD 19.58 |
ALGN 11.90 |
EW 11.35 |
| Liabilities to Equity | 0.35 | 9/10 | TNDM 2.68 |
DXCM 2.08 |
PODD 1.55 |
MDT 0.82 |
BSX 0.80 |
ABT 0.70 |
ALGN 0.61 |
ZBH 0.48 |
EW 0.35 |
SYK 0.00 |
| ROA | 0.32 | 1/10 | EW 32% | ABT 16% | PODD 14% | DXCM 9% | SYK 7% | ALGN 7% | BSX 5% | MDT 5% | ZBH 3% | TNDM -10% |
| ROE | 0.44 | 1/10 | EW 44% |
PODD 35% |
ABT 28% |
DXCM 27% |
ALGN 11% |
MDT 9% |
BSX 8% |
SYK 7% |
ZBH 5% |
TNDM -36% |
| Current Ratio | 3.86 | 1/10 | EW 3.86 |
ZBH 3.08 |
ALGN 2.63 |
ABT 2.43 |
BSX 2.27 |
MDT 2.23 |
PODD 1.65 |
DXCM 1.48 |
TNDM 1.37 |
SYK -1.00 |
| Quick Ratio | 1.32 | 1/10 | BSX 80.98 |
DXCM 50.94 |
SYK 47.71 |
PODD 44.63 |
ZBH 33.50 |
ALGN 29.49 |
MDT 27.46 |
ABT 16.41 |
EW 10.03 |
TNDM -1.00 |
| Long Term Debt to Equity | 0.07 | 7/10 | TNDM} 1.58 |
DXCM} 0.62 |
MDT} 0.49 |
BSX} 0.43 |
ZBH} 0.37 |
ABT} 0.28 |
EW} 0.07 |
ALGN} 0.02 |
SYK} 0.00 |
PODD} 0.00 |
| Debt to Equity | 0.07 | 8/10 | TNDM 1.80 |
DXCM 1.20 |
MDT 0.54 |
BSX 0.51 |
ZBH 0.43 |
ABT 0.32 |
SYK 0.28 |
EW 0.07 |
PODD 0.07 |
ALGN 0.02 |
| Burn Rate | -1.21 | 8/10 | MDT 3.86 |
DXCM 2.93 |
TNDM 2.27 |
BSX 1.63 |
SYK 1.46 |
ABT -0.92 |
ZBH -1.00 |
EW -1.21 |
ALGN -10.41 |
PODD -11.95 |
| Cash to Cap | 0.09 | 1/10 | EW 0.09 |
ALGN 0.08 |
TNDM 0.05 |
PODD 0.05 |
ABT 0.03 |
SYK 0.03 |
ZBH 0.02 |
DXCM 0.02 |
MDT 0.01 |
BSX 0.00 |
| CCR | 0.10 | 5/10 | BSX 2.05 |
MDT 1.62 |
DXCM 1.17 |
ABT 0.23 |
EW 0.10 |
TNDM -51.33 |
ZBH |
SYK |
PODD |
ALGN |
| EV to EBITDA | 96.18 | 6/10 | TNDM} 421.12 |
SYK} 260.47 |
PODD} 162.84 |
BSX} 158.48 |
DXCM} 129.02 |
EW} 96.18 |
ALGN} 79.56 |
ABT} 76.04 |
MDT} 59.24 |
ZBH} -1.00 |
| EV to Revenue | 6.60 | 5/10 | BSX 9.59 |
PODD 9.37 |
DXCM 7.75 |
SYK 6.70 |
EW 6.60 |
ABT 5.42 |
MDT 4.29 |
ALGN 2.87 |
TNDM 1.68 |
ZBH -1.00 |